7 result(s) found for: Auxology.
Displaying page 1 of 1.
| EudraCT Number: 2020-006161-11 | Sponsor Protocol Number: RC31/20/0421 | Start Date*: 2021-06-23 |
| Sponsor Name: Toulouse University Hospital | ||
| Full Title: LONG -TERM INTERVENTIONAL FOLLOW-UP STUDY UP TO 4 YEARS OF AGE OF CHILDREN WITH PRADER-WILLI SYNDROME INCLUDED IN THE OTBB3 CLINICAL TRIAL AND COMPARISON WITH AN UNTREATED COHORT OF CHILDREN WITH P... | ||
| Medical condition: Prader-willi syndrome | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-001939-21 | Sponsor Protocol Number: GX-H9-003 | Start Date*: 2015-07-16 | |||||||||||
| Sponsor Name:Genexine, Inc. | |||||||||||||
| Full Title: A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid Fc fused recombinant human growth hormone (GX-H9) in paediatric patients with growth hormone defic... | |||||||||||||
| Medical condition: Growth Hormone Deficiency (GHD) in pre-pubertal children | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) CZ (Prematurely Ended) SK (Completed) GR (Completed) PL (Completed) EE (Prematurely Ended) LT (Prematurely Ended) LV (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-004526-72 | Sponsor Protocol Number: 1 | Start Date*: 2006-03-02 |
| Sponsor Name:Addenbrooke's NHS Trust | ||
| Full Title: A randomised controlled study of continuous subcutaneous insulin infusion (CSII) therapy compared to conventional bolus insulin treatment in preschool aged children with Type 1 diabetes. | ||
| Medical condition: Type 1 Diabetes Mellitus | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-003099-39 | Sponsor Protocol Number: LWH0604 | Start Date*: 2008-08-21 |
| Sponsor Name:Liverpool Women's NHS Foundation Trust Hospital | ||
| Full Title: A Randomised Controlled Trial of Thyroxine in Preterm Infants Under 28 weeks' Gestation. | ||
| Medical condition: Hypothyroidism is a condition where there is a lack of thyroid hormone in the body. Thyroid hormones are important for normal brain development and growth. Children who are born with low thyroid ho... | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003874-42 | Sponsor Protocol Number: CP-4-006 | Start Date*: 2017-09-04 | |||||||||||
| Sponsor Name:OPKO Biologics Ltd. | |||||||||||||
| Full Title: A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency | |||||||||||||
| Medical condition: Growth hormone deficiency in pre-pubertal children | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) BG (Completed) FR (Completed) PL (Completed) ES (Ongoing) GR (Completed) IT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-020742-10 | Sponsor Protocol Number: 8-79-52800-011 | Start Date*: 2011-05-09 | |||||||||||
| Sponsor Name:Ipsen Pharma | |||||||||||||
| Full Title: Recombinant Human Insulin-like Growth Factor (rhIGF-1) and Growth Hormone (rhGH) Combination Therapy of Pre-Pubertal Children with Idiopathic Growth Hormone Deficiency and Poor Response to First Ye... | |||||||||||||
| Medical condition: Pre-Pubertal Children with Idiopathic Growth Hormone Deficiency | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) SE (Prematurely Ended) FI (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-004553-60 | Sponsor Protocol Number: CP-4-004 | Start Date*: 2012-01-10 |
| Sponsor Name:OPKO Biologics Ltd. | ||
| Full Title: Safety and dose finding study of different MOD-4023 dose levels compared to daily r-hGH therapy in pre-pubertal growth hormone deficient children | ||
| Medical condition: Pediatric Growth Hormone Deficiency | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: HU (Completed) SK (Ongoing) CZ (Prematurely Ended) GR (Completed) PL (Completed) BG (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
